ENSOMA Trademark

Trademark Overview

On Thursday, June 25, 2020, a trademark application was filed for ENSOMA with the United States Patent and Trademark Office. The USPTO has given the ENSOMA trademark a serial number of 90975445. The federal status of this trademark filing is REGISTERED as of Tuesday, September 14, 2021. This trademark is owned by Veevo Biomedicines, Inc.. The ENSOMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

pharmaceutical research and product development
ensoma

General Information

Serial Number90975445
Word MarkENSOMA
Filing DateThursday, June 25, 2020
Status700 - REGISTERED
Status DateTuesday, September 14, 2021
Registration Number6488273
Registration DateTuesday, September 14, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 17, 2020

Trademark Statements

Goods and Servicespharmaceutical research and product development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 22, 2020
Primary Code042
First Use Anywhere DateThursday, February 11, 2021
First Use In Commerce DateThursday, February 11, 2021

Trademark Owner History

Party NameENSOMA, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02111
Party NameENSOMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02111
Party NameENSOMA, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressBOSTON, MA 02116
Party NameVeevo Biomedicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events

Event DateEvent Description
Tuesday, September 14, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, August 11, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 10, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 28, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 23, 2021USE AMENDMENT FILED
Wednesday, July 28, 2021DIVISIONAL PROCESSING COMPLETE
Wednesday, June 23, 2021DIVISIONAL REQUEST RECEIVED
Monday, July 19, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 23, 2021TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, June 23, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, January 12, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 17, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 28, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 8, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 7, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, October 7, 2020ASSIGNED TO LIE
Wednesday, October 7, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 7, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, October 7, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, September 28, 2020ASSIGNED TO EXAMINER
Wednesday, July 29, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 29, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

ensoma development product research pharmaceutical